|
Orthologous residues
|
|
FOXO3A (human): S315‑p, FOXO3A (mouse): S314‑p, FOXO3A (rat): S314‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
electrophoretic mobility shift, mutation of modification site, phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
293 (epithelial), 293T (epithelial), CCL39 (fibroblast)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
hamster, human
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
SGK1 (human)
|
transfection of inactive enzyme
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
IGF-1
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
intracellular localization
|
|
Effect of modification (process):
apoptosis, inhibited, cell cycle regulation, transcription, altered
|